IL ‐ 17A Induces Circadian Disruptions Through the Epigenetic Repression of BMAL1 in Mice With Alzheimer's Disease
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Ting Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Basic Medical Science, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China. Hauptthemen laut MEDLINE: ARNTL Transcription Factors, Alzheimer Disease, Interleukin-17, Epigenesis, Genetic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanxi Province, Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi, Science Research Start-up Fund for Doctor of Shanxi Medical University.
Themen: Demenz
Abstract (Originalsprache)
Circadian disruptions and neuroinflammation impact nearly all people with Alzheimer's disease (AD), but their relationships with each other and the impact of their interaction on AD remain to be addressed. Here, we found that amyloid (A)‐β treatment downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator‐like (BMAL) 1 through the hypermethylation of its promoter region in HT22 cells and that the inhibition of DNA methylation ameliorated circadian rhythm disorders and restored BMAL1 protein expression by reversing its hypermethylation in APPswe/PSEN1dE9 (APP/PS1) mice. Critically, increased levels of interleukin (IL)‐17A contributed to BMAL1 downregulation through the hypermethylation of its promoter region, thus leading to circadian disruptions in APP/PS1 mice. Moreover, we revealed that the mitogen‐activated protein kinase (MAPK) pathway was responsible for IL‐17A‐induced DNA methyltransferase (DNMT) 1 upregulation. Taken together, we elucidate a new mechanism connecting IL‐17A with altered DNA methylation of Bmal1 , which results in circadian disturbances in an AD mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Basic Medical Science, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
- Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
ORCID-Profile: Ting Liu, Li Wang, Xiaohui Wang
Förderung
- Natural Science Foundation of Shanxi Province
- Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi
- Science Research Start-up Fund for Doctor of Shanxi Medical University
- Central Guiding Local Science and Technology Development Fund Projects
- National Natural Science Foundation of China
Zitieren
APA
Liu, T., Mao, T., Fan, J., Shen, Y., Xue, L., Du, K., Li, Y., Wang, L., & Wang, X. (2025). IL ‐ 17A Induces Circadian Disruptions Through the Epigenetic Repression of BMAL1 in Mice With Alzheimer's Disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70546
Vancouver
Liu T, Mao T, Fan J, Shen Y, Xue L, Du K, et al. IL ‐ 17A Induces Circadian Disruptions Through the Epigenetic Repression of BMAL1 in Mice With Alzheimer's Disease. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70546
BibTeX
@article{Liu2025,
author = {Liu, Ting and Mao, Tian and Fan, Jinxuan and Shen, Yanjun and Xue, Lingxia and Du, Kaili and Li, Yang and Wang, Li and Wang, Xiaohui},
title = {IL ‐ 17A Induces Circadian Disruptions Through the Epigenetic Repression of BMAL1 in Mice With Alzheimer's Disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70546}
}
EUVIMED